|

The Hepatitis C Transplant Collaborative

RECRUITINGSponsored by Baylor Research Institute
Actively Recruiting
SponsorBaylor Research Institute
Started2019-09-16
Est. completion2030-12
Eligibility
Age18 Years+
Healthy vol.Accepted
Locations1 site
View on ClinicalTrials.gov →

NCT04493385

Summary

In this study we seek to test the hypothesis that safety and clinical outcomes after cardiac transplantation utilizing HCV NAT+ donor organs as currently performed are acceptable.

Eligibility

Age: 18 Years+Healthy volunteers accepted
Inclusion Criteria:

1. Recipient of a proven HCV NAT+ donor heart.
2. Re-transplant patients will be included.

Exclusion Criteria:

1\. Multi-organ transplantation

Conditions4

Heart DiseaseHepatitis CLiver DiseaseTransplant; Failure, Heart

Locations1 site

Baylor Scott & White Health Research Institute
Dallas, Texas, 75246
Joost Felius, PhD214-818-8943Joost.Felius@BSWHEALTH.ORG

Browse More Trials

Heart Disease trialsLiver Disease trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.